Opicapone Analysis of Health Economic Costs in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study

被引：0
|
作者：
Lees, A.
Reichmann, H.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
LEVODOPA; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
505
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [21] Effect of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Parkinson's disease questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience
    Rocha, F.
    Tolosa, E.
    Ferreira, J.
    Rascol, O.
    Poewe, W.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [22] Effect of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Parkinson's Disease Questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience
    Rocha, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Rascol, O.
    Poewe, W.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S78 - S79
  • [23] Efficacy of opicapone according to different levodopa daily intakes in Parkinson's disease patients with motor fluctuations
    Ebersbach, G.
    Poewe, W.
    Ferreira, J.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S169 - S170
  • [24] Opicapone in German Parkinson's disease patients with motor fluctuations: Results on WOQ-9, QoL and non-motor symptoms.
    Reichmann, H.
    Eggert, K.
    Oehlwein, C.
    Warnecke, T.
    Lees, A.
    Kemmer, M.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 768 - 768
  • [25] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: The BIPARK-I double-blind experience
    Kulisevsky, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Gama, H.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S106 - S106
  • [26] Efficacy of opicapone in different levodopa-containing treatment regimens in Parkinson's disease patients with motor fluctuations
    Antonini, A.
    Ebersbach, G.
    Rascol, O.
    Ikedo, F.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S435 - S436
  • [27] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Patient and Clinical Global Impression of Change from the BIPARK-I double-blind experience
    Rocha, J.
    Stocchi, F.
    Lees, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S79 - S79
  • [28] Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Patient and clinical global impression of change from the BIPARK-I double-blind experience
    Rocha, F.
    Stocchi, F.
    Lees, A.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [29] Efficacy and safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 659 - 660
  • [30] Efficacy and Safety of Opicapone in Parkinson's Disease Patients According to Duration of Motor Fluctuations: Post-Hoc Analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S444 - S444
12345